High density lipoprotein and coronary heart disease.
作者信息
Betteridge D J
机构信息
Department of Medicine, University College and Middlesex School of Medicine, London.
出版信息
BMJ. 1989 Apr 15;298(6679):974-5. doi: 10.1136/bmj.298.6679.974.
Abstract
摘要
相似文献
1
High density lipoprotein and coronary heart disease.高密度脂蛋白与冠心病
BMJ. 1989 Apr 15;298(6679):974-5. doi: 10.1136/bmj.298.6679.974.
2
The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations.高密度脂蛋白（HDL）胆固醇在冠心病预防和治疗中的作用：专家组建议
Am J Cardiol. 2002 Jul 15;90(2):139-43. doi: 10.1016/s0002-9149(02)02436-0.
3
Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.已确诊冠心病或风险等同情况且低密度脂蛋白胆固醇得到控制的患者中低高密度脂蛋白胆固醇的患病率。
Am J Cardiol. 2007 Nov 15;100(10):1499-501. doi: 10.1016/j.amjcard.2007.06.058. Epub 2007 Sep 27.
4
Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.高密度脂蛋白胆固醇与低密度脂蛋白胆固醇分类下的冠心病风险的相关性：社区动脉粥样硬化风险研究。
Am J Med Sci. 2011 Mar;341(3):173-80. doi: 10.1097/MAJ.0b013e3181f97e4a.
5
Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).冠心病患者中提高高密度脂蛋白胆固醇的临床获益与血清低密度脂蛋白胆固醇水平的关系（来自苯扎贝特预防心肌梗死试验）
Am J Cardiol. 2009 Jan 1;103(1):41-5. doi: 10.1016/j.amjcard.2008.08.033. Epub 2008 Oct 10.
6
High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.高密度脂蛋白胆固醇和甘油三酯作为预防和治疗冠状动脉疾病的治疗靶点。
Am Heart J. 2002 Dec;144(6 Suppl):S33-42. doi: 10.1067/mhj.2002.130301.
7
Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.血脂异常女性低密度脂蛋白胆固醇和高密度脂蛋白胆固醇目标达成情况：脂质治疗评估项目（L-TAP）2
Am Heart J. 2009 Nov;158(5):860-6. doi: 10.1016/j.ahj.2009.08.009.
8
[Relation between lipoprotein cholesterol and hypertension and coronary heart disease].[脂蛋白胆固醇与高血压及冠心病之间的关系]
Zhonghua Xin Xue Guan Bing Za Zhi. 1985 Sep;13(4):273-4.
9
10
Total cholesterol, low density lipoprotein cholesterol, and high density lipoprotein cholesterol and coronary heart disease in Scotland.苏格兰的总胆固醇、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇与冠心病
BMJ. 1991 Sep 21;303(6804):678-81. doi: 10.1136/bmj.303.6804.678.
引用本文的文献
1
HDL as an independent risk factor in British men (and women).高密度脂蛋白作为英国男性（及女性）的一个独立风险因素。
BMJ. 1989 May 6;298(6682):1249. doi: 10.1136/bmj.298.6682.1249-a.
2
Brisk walking and high density lipoprotein cholesterol.快走与高密度脂蛋白胆固醇
BMJ. 1990 Jan 20;300(6718):195-6. doi: 10.1136/bmj.300.6718.195-b.
本文引用的文献
1
2
Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man.高密度脂蛋白载脂蛋白对人体纤维蛋白溶解的激活作用。
Thromb Res. 1985 Jul 1;39(1):1-8. doi: 10.1016/0049-3848(85)90116-1.
3
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.冠心病发病率与脂蛋白胆固醇水平。弗雷明汉姆研究。
JAMA. 1986 Nov 28;256(20):2835-8.
4
The triglyceride issue: a view from Framingham.甘油三酯问题：来自弗雷明汉的观点。
Am Heart J. 1986 Aug;112(2):432-7. doi: 10.1016/0002-8703(86)90296-6.
5
6
7
High-density lipoprotein: a major risk factor for coronary atherosclerosis.高密度脂蛋白：冠状动脉粥样硬化的主要危险因素。
Baillieres Clin Endocrinol Metab. 1987 Aug;1(3):603-22. doi: 10.1016/s0950-351x(87)80025-3.
8
Apolipoprotein A-I gene polymorphism associated with premature coronary artery disease and familial hypoalphalipoproteinemia.载脂蛋白A-I基因多态性与早发冠状动脉疾病及家族性低α脂蛋白血症相关。
N Engl J Med. 1986 Mar 13;314(11):671-7. doi: 10.1056/NEJM198603133141102.
9
The interaction of high-density lipoproteins with extrahepatic cells.
Am Heart J. 1987 Feb;113(2 Pt 2):549-50. doi: 10.1016/0002-8703(87)90630-2.
10
High-density lipoproteins and atherosclerosis.
Biochem Soc Trans. 1978;6(5):888-93. doi: 10.1042/bst0060888.
Zotero 插件